{"id":1597,"date":"2021-04-16T10:00:41","date_gmt":"2021-04-16T10:00:41","guid":{"rendered":"http:\/\/3.6.159.88\/?p=1597"},"modified":"2023-02-18T05:42:07","modified_gmt":"2023-02-18T05:42:07","slug":"get-ready-to-surf-indias-health-tech-wave","status":"publish","type":"post","link":"https:\/\/trica.co\/capital\/blog\/get-ready-to-surf-indias-health-tech-wave\/","title":{"rendered":"Get ready to surf India\u2019s health tech wave"},"content":{"rendered":"<p><span style=\"font-weight: 400;\">At the height of the first wave of the pandemic last year, a friend was stuck in her home town far away from the nearest big city and had a complication linked to a chronic health condition. This in itself wasn\u2019t new but she needed to consult her doctor for a prescription and due to the restrictions and the pandemic going to the hospital was too risky. Her daughter used an online consultation app and she was able to do a video call with her regular doctor whose <\/span><b>practice<\/b><span style=\"font-weight: 400;\"> was two hours away and she got the right treatment. What is exceptional about this anecdote is that it is not exceptional anymore in India. Stuck at home and worried about visiting hospitals or medical shops, millions of Indians have turned to online platforms to consult with doctors, order medicines and get diagnostic tests done in the past year. <\/span><b>E-pharmacies<\/b><span style=\"font-weight: 400;\"> saw a 200% increase in the number of orders in 2020, while consultations on tele-consultation platforms increased by 300%, according to a recent <\/span><b>health tech<\/b><span style=\"font-weight: 400;\"> report by IAMAI-Praxis. It has been a transformational year for Indian healthcare, specifically <\/span><b>health tech<\/b><span style=\"font-weight: 400;\">.<\/span><\/p>\n<p><strong> PICTURE ABHI BAKI HAI!\u00a0<\/strong><\/p>\n<p><span style=\"font-weight: 400;\">We are just scratching the surface when it comes to exploring the possibilities that the intersection of health and tech can come up with. Why do I say this? Solving demand supply gaps within the existing ecosystem is always the first stage in any sector that tech transforms. At this stage the innovation or the tech intervention is in discovery and delivery. We have seen this with e-commerce and even to a large extent with <\/span><b>edtech<\/b><span style=\"font-weight: 400;\">. The business models in <\/span><b>health tech<\/b><span style=\"font-weight: 400;\"> that have gained traction and have scaled are in segments like online medicine delivery, tele-consulting, and tech solutions for doctors and hospitals and other healthcare service providers. 1mg, <\/span><b>PharmEasy<\/b><span style=\"font-weight: 400;\">, and Practo are some of the best known examples that fall in this category. Startups <\/span><b>focussing<\/b><span style=\"font-weight: 400;\"> on preventive healthcare, fitness, and lifestyle-linked health solutions with the use of wearables and nutrition have also come up, primarily targeted at the top 1% of Indians, which is still a significant population.<\/span><\/p>\n<p><img loading=\"lazy\" class=\"alignnone size-full wp-image-1599\" src=\"https:\/\/capital-blog.trica.co\/wp-content\/uploads\/2022\/04\/HT1.png\" alt=\"\" width=\"964\" height=\"331\" \/><\/p>\n<p><span style=\"font-weight: 400;\">Startups like CureFit are in this segment. Much of the $3.4 billion that has flown into <\/span><b>health tech<\/b><span style=\"font-weight: 400;\"> between 2014 and 2020 has been cornered by such startups. Earlier this year, <\/span><b>Innovaccer<\/b><span style=\"font-weight: 400;\"> became India\u2019s first <\/span><b>health tech<\/b><span style=\"font-weight: 400;\"> unicorn. It analyses healthcare data to offer actionable insights to doctors, hospitals, and insurance companies. <strong>So far we have seen tech-enabled innovations; the next phase will be tech-led and there are multiple global examples of this trend.<\/strong> Like genetic testing company <\/span><b>23andMe<\/b><span style=\"font-weight: 400;\">, which Richard Branson is trying to take public through a SPAC reverse merger. <\/span><b>23andMe<\/b><span style=\"font-weight: 400;\"> has started co-developing drugs using its massive genetic database and has also partnered with a hot <\/span><b>artificial intelligence<\/b><span style=\"font-weight: 400;\"> (<\/span><b>A.I.)<\/b><span style=\"font-weight: 400;\">-based chronic disease management startup <\/span><b>called <\/b><span style=\"font-weight: 400;\">Lark Health.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Another one is <\/span><b>the U.K.<\/b><span style=\"font-weight: 400;\">-based BenevolentAI, which uses A.I. for drug discovery and has been valued at over $2 billion.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">\u00a0<\/span><b>Segments to watch<\/b><\/p>\n<p><span style=\"font-weight: 400;\">Every link in the healthcare chain in India is plagued by severe infrastructural issues and is ripe for disruption and tech intervention. However, from a startup and investment point of view, it will be in diagnostics, R<\/span><b>&amp;D, and<\/b><span style=\"font-weight: 400;\"> deep science that we will see the most breakthroughs in the near future. To be fair, we have seen startups that have used <\/span><b>A.I.<\/b><span style=\"font-weight: 400;\">, <\/span><b>machine learning <\/b><span style=\"font-weight: 400;\">(ML), data analytics, and deep science R&amp;D come up with innovative solutions built for India.<\/span><\/p>\n<p><img loading=\"lazy\" class=\"alignnone size-full wp-image-1598\" src=\"https:\/\/capital-blog.trica.co\/wp-content\/uploads\/2022\/04\/HT2.png\" alt=\"\" width=\"973\" height=\"624\" \/><\/p>\n<p><span style=\"font-weight: 400;\">However, such examples are few, and fewer have seen growth and scale. But my bet is that we have reached the inflection point and we will see more innovative startups come up and find large markets.<\/span><\/p>\n<p><b>What&#8217;s the booster shot?<\/b><\/p>\n<p><span style=\"font-weight: 400;\">There are many factors that support my view.<\/span><span style=\"font-weight: 400;\">\u00a0<\/span><\/p>\n<ul>\n<li><i><span style=\"font-weight: 400;\">Indians were already getting more comfortable with tech pre-<\/span><\/i><b><i>Covid<\/i><\/b><b>&#8211;<\/b><b><i>19<\/i><\/b><span style=\"font-weight: 400;\">: Habit-changing products and services like the smartphone, WhatsApp, TikTok and similar social media and entertainment apps, online <\/span><b>retail, and<\/b><span style=\"font-weight: 400;\"> digital <\/span><b>payments<\/b><span style=\"font-weight: 400;\"> solutions have reached almost all parts of India\u2019s deep hinterland. Telemedicine has also been around for a couple of decades, but has seen a push in the past few years with startups coming up in this space. Covid-19 turbocharged this move towards tech and almost overnight Indians have accepted online health and health-adjacent solutions as reliable. <\/span><b>Covid-19<\/b><span style=\"font-weight: 400;\"> also prompted the <\/span><b>government<\/b><span style=\"font-weight: 400;\"> to release official telemedicine guidelines ensuring legitimacy. The government\u2019s eSanjeevani initiative, or the <\/span><b>national telemedicine service<\/b><span style=\"font-weight: 400;\">, which was launched in November 2019, <\/span><b>had<\/b><span style=\"font-weight: 400;\"> facilitated <\/span><b>3 million<\/b><span style=\"font-weight: 400;\"> consultations by March 2021.<\/span><span style=\"font-weight: 400;\"><br \/>\n<\/span>The increasing comfort with the smartphone\u2014about 760 million Indians are estimated to own <b style=\"font-size: 1.1429rem;\">one<\/b><span style=\"font-weight: 400;\">\u2014is resulting in personal diagnostic solutions getting built around it. For instance, there are health apps that let the user check heart rates, <\/span><b style=\"font-size: 1.1429rem;\">oxygen levels, blood pressure, and other<\/b><span style=\"font-weight: 400;\"> such health indicators with a sensor linked to the smartphone.<\/span><span style=\"font-weight: 400;\">\u00a0<\/span><\/li>\n<\/ul>\n<ul>\n<li><i><span style=\"font-weight: 400;\">India already has a robust pharma supply chain infrastructure:<\/span><\/i><span style=\"font-weight: 400;\"> We do everything from production of vials to medicines to injections to vaccines. Our manufacturing prowess in the health-related space is so strong that India went from importer of PPE kits to the <\/span><b>second-largest<\/b><span style=\"font-weight: 400;\"> producer globally in just two months. We have already witnessed how this ecosystem worked together to create a <\/span><b>home-grown<\/b><span style=\"font-weight: 400;\"> Covid-19 vaccine, making India one of the few countries to have come up with its own. Further, India is among the largest manufacturers of the Oxford-AztraZeneca Covid-19 vaccine, thanks to <\/span><b>the Pune-based<\/b><span style=\"font-weight: 400;\"> Serum Institute <\/span><b>of India<\/b><span style=\"font-weight: 400;\">. This apart, we already have a relatively <\/span><b>well-entrenched<\/b><span style=\"font-weight: 400;\"> R&amp;D and clinical trials framework in place, though better transparency and trustworthiness is urgently needed. India can become a critical hub for <\/span><b>tech-driven<\/b><span style=\"font-weight: 400;\"> medical R&amp;D as we have the advantage of <\/span><b>a large<\/b><span style=\"font-weight: 400;\"> population.<\/span><span style=\"font-weight: 400;\"><br \/>\n<\/span>Large sample sizes will further <b style=\"font-size: 1.1429rem;\">A.I.<\/b><span style=\"font-weight: 400;\"> and <\/span><b style=\"font-size: 1.1429rem;\">deep-tech<\/b><span style=\"font-weight: 400;\"> development at a faster pace and scale can also be achieved much quicker. The scientists<\/span><b style=\"font-size: 1.1429rem;\">, doctors, and<\/b><span style=\"font-weight: 400;\"> other core health professionals who work in pharma and the medical devices space have worked with <\/span><b style=\"font-size: 1.1429rem;\">best-in-class<\/b><span style=\"font-weight: 400;\"> R&amp;D labs and companies to handle clinical trials and production of medicines and devices. We will see increasing numbers of such experts using this knowledge to develop their own <\/span><b style=\"font-size: 1.1429rem;\">R&amp;D-led<\/b><span style=\"font-weight: 400;\"> products, leveraging India\u2019s medical supply chain.<\/span><span style=\"font-weight: 400;\">\u00a0<\/span><\/li>\n<li><i><span style=\"font-weight: 400;\">A large home market:<\/span><\/i><span style=\"font-weight: 400;\"> While we typically focus on India\u2019s large young population, the country\u2019s aging population is also big and rapidly growing. The over-60 accounted for 8.6% of the population in the 2011 Census. Growing at around 3% annually, the number will rise to 319 million in 2050. About 70% of India\u2019s seniors have at least one chronic health issue. Many Indians are moving firmly to preventive healthcare and are more aware of and <\/span><b>focussed<\/b><span style=\"font-weight: 400;\"> on better health. There is also a lack of trust in the regular healthcare delivery systems. So tech solutions that help Indians avoid hospitals will find takers. Yes, questions over whether the <\/span><b>rest of India<\/b><span style=\"font-weight: 400;\"> will pay are relevant, considering the low spending power of much of India. <\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">However, healthcare is a necessary expense and with insurance penetration still low, healthcare is prohibitively expensive for most. We have all heard of people falling into debt just to get access to good healthcare for their family members. In fact, it is estimated that 50 <\/span><b>million<\/b><span style=\"font-weight: 400;\">-60 million people fall into poverty due to a healthcare crisis in the family. Here again the <\/span><b>government <\/b><span style=\"font-weight: 400;\">has introduced numerous insurance measures, especially for below-poverty-line households, like Rashtriya Swasthya Bima Yojana and Ayushman Bharat. Startups are also innovating and <\/span><b>insure-tech<\/b><span style=\"font-weight: 400;\"> startups like <\/span><b>Turtlemint<\/b><span style=\"font-weight: 400;\">, Acko, RenewBuy, PolicyBazaar, Digit, and Coverfox are increasing access to insurance, ensuring more Indians will be able to afford quality healthcare.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">The National Health Stack guidelines by <\/span><b>the<\/b><span style=\"font-weight: 400;\"> NITI Aayog will provide a further fillip to startups; much like UPI and <\/span><b>the<\/b><span style=\"font-weight: 400;\"> India Stack did for fintech. There are challenges, from poor infrastructure to dearth of talent, but then which sector in India does not face these issues? Indian entrepreneurs have shown the gumption to build around these challenges. We have all the basic ingredients ready and in place today\u2014a great pharma and medical supply chain, large population, intent among health professionals to innovate and <\/span><b>start up<\/b><span style=\"font-weight: 400;\">, and now willingness among customers to try new solutions. The future of Indian <\/span><b>health tech<\/b><span style=\"font-weight: 400;\"> is healthy.<\/span><span style=\"font-weight: 400;\">\u00a0<\/span><\/p>\n<p><img loading=\"lazy\" class=\"alignnone size-full wp-image-1559\" src=\"https:\/\/capital-blog.trica.co\/wp-content\/uploads\/2022\/04\/small-line.png\" alt=\"\" width=\"398\" height=\"31\" \/><\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>At the height of the first wave of the pandemic last year, a friend was stuck in her home town far away from the nearest big city and had a complication linked to a chronic health condition. This in itself wasn&rsquo;t new but she needed to consult her doctor for a prescription and due to the restrictions and the pandemic going to the hospital was too risky. Her daughter used an online consultation app and she was able to do a video call with her regular doctor whose practice was two hours away and she got the right treatment. What [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":1531,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0},"categories":[41],"tags":[89,87,86,85,88,58],"authors":[{"term_id":153,"user_id":0,"is_guest":1,"slug":"team-trica","display_name":"Team Trica"}],"_links":{"self":[{"href":"https:\/\/trica.co\/capital\/blog\/wp-json\/wp\/v2\/posts\/1597"}],"collection":[{"href":"https:\/\/trica.co\/capital\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/trica.co\/capital\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/trica.co\/capital\/blog\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/trica.co\/capital\/blog\/wp-json\/wp\/v2\/comments?post=1597"}],"version-history":[{"count":4,"href":"https:\/\/trica.co\/capital\/blog\/wp-json\/wp\/v2\/posts\/1597\/revisions"}],"predecessor-version":[{"id":1799,"href":"https:\/\/trica.co\/capital\/blog\/wp-json\/wp\/v2\/posts\/1597\/revisions\/1799"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/trica.co\/capital\/blog\/wp-json\/wp\/v2\/media\/1531"}],"wp:attachment":[{"href":"https:\/\/trica.co\/capital\/blog\/wp-json\/wp\/v2\/media?parent=1597"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/trica.co\/capital\/blog\/wp-json\/wp\/v2\/categories?post=1597"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/trica.co\/capital\/blog\/wp-json\/wp\/v2\/tags?post=1597"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}